MedinCell S.A.
MDCLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $25,541 | $9,160 | $9,944 | $4,090 |
| % Growth | 178.8% | -7.9% | 143.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $25,541 | $9,160 | $9,944 | $4,090 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $24,313 | $21,076 | $27,925 | $23,607 |
| G&A Expenses | $0 | $9,153 | $7,128 | $6,214 |
| SG&A Expenses | $529 | $11,792 | $9,716 | $8,486 |
| Sales & Mktg Exp. | $529 | $2,639 | $2,588 | $2,272 |
| Other Operating Expenses | $11,539 | -$2,337 | $0 | $0 |
| Operating Expenses | $36,381 | $30,137 | $33,989 | $27,904 |
| Operating Income | -$10,840 | -$20,977 | -$24,025 | -$23,814 |
| % Margin | -42.4% | -229% | -241.6% | -582.2% |
| Other Income/Exp. Net | -$7,438 | -$3,973 | -$7,964 | -$994 |
| Pre-Tax Income | -$18,278 | -$24,950 | -$32,010 | -$24,806 |
| Tax Expense | $160 | $88 | $0 | $0 |
| Net Income | -$18,438 | -$25,038 | -$32,010 | -$24,806 |
| % Margin | -72.2% | -273.3% | -321.9% | -606.5% |
| EPS | -0.63 | -0.88 | -1.27 | -1 |
| % Growth | 28.4% | 30.7% | -27% | – |
| EPS Diluted | -0.63 | -0.88 | -1.27 | -1 |
| Weighted Avg Shares Out | 29,101 | 28,420 | 25,188 | 24,865 |
| Weighted Avg Shares Out Dil | 29,101 | 28,420 | 25,188 | 24,865 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$44 | $1 | $46 |
| Interest Expense | $5,088 | $4,617 | $3,932 | $1,844 |
| Depreciation & Amortization | $1,990 | $1,719 | $1,665 | $1,516 |
| EBITDA | -$11,200 | -$18,614 | -$26,413 | -$21,446 |
| % Margin | -43.9% | -203.2% | -265.6% | -524.4% |